| Literature DB >> 31718055 |
Kateřina Skopalová1, Zdenka Capáková1, Patrycja Bober2, Jana Pelková3,4, Jaroslav Stejskal2, Věra Kašpárková1,5, Marián Lehocký1,5, Ita Junkar6, Miran Mozetič6, Petr Humpolíček1,5.
Abstract
Hemocompatibility is an essential prerequisite for the application of materials in the field of biomedicine and biosensing. In addition, mixed ionic and electronic conductivity of conducting polymers is an advantageous property for these applications. Heparin-like materials containing sulfate, sulfamic, and carboxylic groups may have an anticoagulation effect. Therefore, sodium dodecylbenzenesulfonate, 2-aminoethane-1-sulfonic acid and N-(2-acetamido)-2-aminoethanesulfonic acid were used for modification of the representative of conducting polymers, polyaniline, and the resulting products were studied in the context of interactions with human blood. The anticoagulation activity was then correlated to surface energy and conductivity of the materials. Results show that anticoagulation activity is highly affected by the presence of suitable functional groups originating from the used heparin-like substances, and by the properties of polyaniline polymer itself.Entities:
Keywords: conducting polymer; hemocompatibility; polyaniline; polymer conductivity
Year: 2019 PMID: 31718055 PMCID: PMC6918175 DOI: 10.3390/polym11111861
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1The formula of (A) PANI hydrochloride, (B) SDBS, (C), taurine, and (D) ACES.
The surface energy of modified PANI surfaces, γtot, determined immediately after preparation, and after 7 and 14 days on the stored under laboratory conditions. The values are compared with γtot of neat PANI-S and PANI-B films.
| γtot ± SD (mN·m−1) | |||
|---|---|---|---|
| Day 0 | Day 7 | Day 14 | |
| PANI-BSDBS | 51 ± 3 | 51 ± 2 | 50 ± 7 |
| PANI-SSDBS | 51 ± 3 | 47 ± 4 | 44 ± 4 |
| PANI-BTaurine | 51 ± 7 | 53 ± 2 | 38 ± 12 |
| PANI-STaurine | 55 ± 8 | 45 ± 7 | 47 ± 2 |
| PANI-BACES | 41 ± 1 | 37 ± 1 | 45 ± 0 |
| PANI-MSDBS | 46 ± 5 | 47 ± 4 | 46 ± 4 |
| PANI-MTaurine | 53 ± 4 | 44 ± 10 | 46 ± 4 |
| PANI-S (a) | 52.54 | n.d. | n.d. |
| PANI-B (a) | 50.88 | n.d. | n.d. |
(a) Reproduced from [21]; n.d. not determined.
The conductivity of bulk PANI (S cm−1) containing the studied substances.
| Sample | Day 0 | Day 7 | Day 14 |
|---|---|---|---|
| PANI-MSDBS | 7.0 ± 0.03 | 5.7 ± 0.002 | 5.2 ± 0.004 |
| PANI-MTaurine | 17.9 ± 0.01 | 16.5 ± 0.004 | 15.8 ± 0.003 |
Impact of PANI with modified surfaces on selected coagulation parameters, prothrombin time (PT), activated partial thromboplastin time (aPPT), thrombin clotting time (TCT), expressed as times to the coagulation start.
| PT [s] | aPPT [s] | TCT [s] | |
|---|---|---|---|
| Reference | 12.1 ± 0.1 | 25.2 ± 0.5 | 16.7 ± 0.3 |
| PANI-BSDBS | 12.2 ± 0.6 | 29.5 ± 4.7 | 20.0 ± 2.2 |
| PANI-SSDBS | 11.8 ± 0.2 | 25.6 ± 0.3 | 18.3 ± 0.3 |
| PANI-BTaurin | 11.8 ± 0.0 | 25.4 ± 0.5 | 17.7 ± 0.5 |
| PANI-STaurin | 11.8 ± 0.2 | 26.9 ± 0.6 | 19.2 ± 0.4 |
| PANI-BACES | 12.3 ± 0.0 | 25.4 ± 0.3 | 15.4 ± 0.4 |
| PANI-MSDBS | 12.0 ± 0.1 | 25.8 ± 0.6 | 18.2 ± 0.5 |
| PANI-MTaurin | 12.1 ± 0.3 | 30.0 ± 2.5 | 19.7 ± 0.6 |
Note: As reference coagulation parameters of donor blood were used. Normal ranges for coagulation parameters of a healthy person: PT 11.0–13.5, aPTT 25–32, TCT below 20 s. The values are expressed as mean value ± standard deviation of three tests.